- Report
- August 2026
- 180 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- August 2026
- 182 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- August 2026
- 180 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- August 2026
- 176 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- August 2026
- 182 Pages
Global
From €2225EUR$2,400USD£1,861GBP
- Report
- August 2026
- 185 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- July 2026
- 90 Pages
United States
From €4404EUR$4,750USD£3,684GBP
- Report
- June 2026
- 180 Pages
United States
From €4404EUR$4,750USD£3,684GBP
- Report
- June 2023
- 186 Pages
Global
From €4311EUR$4,650USD£3,606GBP
- Report
- March 2021
- 216 Pages
Global
From €2550EUR$2,750USD£2,133GBP
- Report
- October 2025
- 150 Pages
Global
From €5516EUR$5,950USD£4,614GBP
- Report
- January 2024
- 150 Pages
Global
From €5516EUR$5,950USD£4,614GBP
- Report
- November 2025
- 120 Pages
Middle East
From €5516EUR$5,950USD£4,614GBP
- Report
- October 2025
- 120 Pages
Global
From €5516EUR$5,950USD£4,614GBP
- Report
- May 2025
- 150 Pages
Global
From €5516EUR$5,950USD£4,614GBP
- Report
- April 2024
- 80 Pages
Europe
From €5516EUR$5,950USD£4,614GBP
- Report
- August 2025
- 188 Pages
Global
From €4172EUR$4,500USD£3,490GBP
- Report
- August 2025
- 191 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- April 2025
- 188 Pages
Global
From €4631EUR$4,995USD£3,874GBP
- Report
- July 2025
- 350 Pages
Global
From €4588EUR$4,949USD£3,838GBP

Imaging biomarkers are a type of biomarker used to measure and monitor biological processes in the body. They are used to detect and diagnose diseases, assess the effectiveness of treatments, and monitor the progression of diseases. Imaging biomarkers are typically used in conjunction with other biomarkers, such as genetic and molecular biomarkers, to provide a more comprehensive picture of a patient's health. Imaging biomarkers can be used to detect changes in the structure and function of organs, tissues, and cells. Examples of imaging biomarkers include MRI, CT, PET, and ultrasound.
Imaging biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and radiology. They are also used in clinical trials to assess the safety and efficacy of new treatments. Imaging biomarkers are becoming increasingly important in the diagnosis and treatment of diseases, as they provide a more detailed picture of a patient's health.
Companies in the imaging biomarker market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Systems. Show Less Read more